The midbody is a singular organelle formed between daughter cells during cytokinesis and required for their final separation. (see below) 12 , but the relationship between MB d loss or retention and the physiological state of cells is unknown.
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During autophagy (macroautophagy), double membrane-bound autophagosomes assemble, engulf cytoplasmic material and fuse with lysosomes for degradation [15] [16] [17] [18] . Autophagy is required for cellular homeostasis, elimination of defective ubiquitin-tagged proteins and organelles [16] [17] [18] [19] , clearing of cell-fate determinants and cell remodeling [20] [21] [22] . Defects in autophagy contribute to many disorders, including neurodegeneration 23 , hepatomegaly 24 and ageing 15, 18 . Here we show that MB d s accumulate in stem cells and are lost on differentiation. They are selectively degraded by linking the NBR1 autophagic receptor to the CEP55 midbody protein. MB d s accumulate by evasion of autophagosome encapsulation, asymmetric inheritance and maintenance of low autophagic activity. Reprogramming efficiency and in vitro tumorigenicity are increased following experimental elevation of MB d levels, indicating non-mitotic roles for these organelles in stem and cancer cells.
RESULTS

Post-mitotic midbodies accumulate within cells
Multiple MB
d s (up to 20) were observed in subpopulations of cells by immunofluorescence, but their precise location was unclear (Fig. 1a,b) . Three-dimensional reconstruction of immunofluorescent images revealed multiple MB d s inside polarized and non-polarized cells (Fig. 1c,d ). Immuno-electron microscopy confirmed this localization and revealed ultrastructural features characteristic of MB d s (refs 8,14 ; Fig. 1e ). About 70% of cell-associated MB d s were trypsin resistant, indicating that they were intracellular (Fig. 1f) . This intracellular localization of MB d s indicated that they might accumulate in cells through successive divisions (see below). MB d s were also released from cells. In two-day co-cultures of HeLa cells stably expressing either monomeric RFP (red fluorescent protein, cytoplasmic marker) or green fluorescent protein (GFP)-tagged MKLP1 (midbody marker), about 7% of MKLP1-GFP + MB d s associated with RFP + cells (Fig. 1g) . Such free MB d s were also generated by other cell types (for example adult human fibroblasts, HeLa; 1-10%). These observations resolve the conflict of previous studies indicating that MB d s are either retained and degraded 9, 11, 12 or released as remnants after abscission 8 . We show that MB d s accumulate in some cells (Fig. 1a-d ) but not others, and it is this cell-type-specific difference in MB d accumulation that is the focus of this study.
MB d s are inherited by the cell with the older centrosome
Multiple MB d s often clustered around the centrosome or spindle pole (ref. 9 and data not shown), reminiscent of MB d -sized aggresomes, which segregate to one daughter cell under control of centrosomes 25, 26 . Moreover, centrosome-age-dependent differences in signalling were observed late in cytokinesis 27 . These centrosomeage-related differences led us to examine the relationship between centrosomes and MB d inheritance. In G1, the centrosome contains one mother centriole and one daughter centriole 3 . After centriole duplication, three generations of centrioles are present: an older mother, a younger mother and two new daughters 3, 27 . The centrosome with the older mother centriole is termed the older centrosome 4, 5 . GFP-tagged centrin-1 (CETN1-GFP; ref. 28 ) expressed in mitotic HeLa cells was brightest at one of the four centrioles (92.2% of cells, n = 116; Fig. 2a ) and turned over very slowly (fluorescence recovery after photobleaching t 1/2 ∼ 4 h and ref. 5). The brightest centriole remained so from metaphase to late cytokinesis (91.3% of cells, n = 46; Supplementary Fig. S1a ), indicating that this was the older mother centriole. This was confirmed by staining with the older-centrosome marker hCenexin1 (ref. 27 ; ∼90% of HeLa and MCF-7 cells, n = 143 and n = 347, respectively; Fig. 2b ). Several other centriole antigens also showed intrinsic age-related differences in labelling ( Supplementary Fig. S1b ).
Using CETN1-GFP to identify the older mother centriole, brightfield imaging to follow midbody dynamics in living cells and immunofluorescence to confirm MB d inheritance, we determined that MB d s were preferentially inherited by the cell with the older centrosome. This was observed in pluripotent human embryonic stem cells (hESCs; 83.3% of H9, n = 18; Fig. 2d ), immortalized somatic cells (91.3% of hRPE-1, n = 23) and cancer cells (84.6% of U2OS, n = 13; 75.0% of HeLa, n = 24; Fig. 2c ). We conclude that most inherited MB d s are asymmetrically transferred to the daughter cell with the older centrosome in several cell types. 
MB d s accumulate in stem cells in vivo
Other studies have shown that the older centrosome is asymmetrically inherited by the stem cell during asymmetric divisions in the Drosophila male germline 4 and the mouse neocortex 5 . The association of the older centrosome with both MB d s and stem-cell divisions led us to ask whether MB d s were found in stem-cell niches. To address this, we determined the localization of MB d s in human and mouse tissues. In seminiferous tubules of testes, MB d s were confined to the basal compartment, the site of germline stem cells and their mitotic progeny (both capable of self-renewal 29, 30 ) (Fig. 3a , up to eight puncta/cell, 5 µm section). Electron microscopy also revealed multiple cytoplasmic structures with features characteristic of MB d s within these cells (Fig. 3b,c) .
In the ventricular zone (Sox2 + ; ref. 31) of embryonic mouse brains, CD133-labelled MB d s were associated with neural progenitors 13, 14 ( Fig. 3d and Supplementary Fig. S2 ). During asymmetric divisions, intracellular MB d s were usually found in ventricle-facing daughter cells (progenitors; 75%, n = 8) and not in daughters with presumed committed fates 5 . MB d s in the human hair follicle were also confined to a subpopulation of cells in the stem-cell niche, the bulge 32 , indicating distinct properties of this subpopulation (Fig. 3e,f Fig. 3g,h ). Differentiation was judged by loss of embryonic stem-cell markers (Oct4, SOX2, KLF4, NANOG) and gain of the CD13 differentiation marker 34, 35 . In contrast, MB d accumulation increased ∼7-fold after reprogramming dH1f cells to induced pluripotent stem cells (iPSCs; refs 34,36; dH1f-iPS; Fig. 3h ,i). We conclude that MB d accumulation in vitro reflects that observed in vivo, and can be manipulated by altering the potency status of cells.
MB d accumulation is enhanced in tumour-derived cells
We next examined differences in MB d accumulation among cell lines derived from stem cells, normal dividing cells and cancer cells (Fig. 4a) . and possess stem-cell properties 38, 39 indicates a relationship between MB d accumulation, tumorigenicity and cancer 'initiating' or 'stem' cells defined by the cancer 'stem cell' (CSC) theory 40 .
MB d accumulation does not correlate with cell proliferation rate
A simple explanation for cell-type-specific differences in MB d accumulation is variability in proliferation rates. Slower division rates could provide more time for MB d degradation, as recently proposed 12 . However, we observed no correlation between population doubling time and MB d accumulation (Fig. 4a) . It was still possible that MB daccumulating cells cycled faster than the bulk population. However, a cohort of cells pulse-labelled with 5-ethynyl-2 -deoxyuridine (EdU; ref. 41 ) showed a proportional decrease in EdU intensity, reflecting dilution of dye after successive divisions (Fig. 4b ) and indicating that MB d -accumulating and non-accumulating subpopulations had similar cycling rates (Fig. 4c,d ). 42 to monitor degradation of MB d s following plasma-membrane permeabilization and protease addition (Fig. 5a) . (Fig. 5b) . Importantly, the integrity of intracellular organelles was maintained during the course of these experiments (Supplementary Fig. S3 ).
MB
A R T I C L E S
Stem cells and cancer cells evade lysosomal degradation of MB d s
The (Fig. 5d) . Three hours after release from mitosis, the percentage of MB d+ cells (MB d levels) peaked at ∼40% (50% being the maximum, because half the cells were 'born' without an MB d ). This was followed by a peak in MB d localization to lysosomes (∼42% at 7 h; Fig. 5d ) and then a decrease of MB d s to baseline levels (16-19 h; Fig. 5d ). These data and the FPP data indicated that MB d s in hRPE-1 cells entered the cytoplasm, moved into lysosomes and were degraded before the next cell cycle (Fig. 5b,d) .
If Fig. 5c ,e) were largely unaffected by lysosomal inhibition (see Supplementary Fig. S4a ). The modest increase in MB d+ HeLa cells (Fig. 5e ) was consistent with their modest MB d -accumulating ability (Fig. 4a) Fig. 4a ). In agreement with this trend was the presence of MB d s in autophagosomes of MB d -poor cells (Fig. 6a) .
Experimental reduction of autophagy activity using mouse embryonic fibroblasts (MEFs) from Atg5-deleted mice 19 or by short interfering RNA (siRNA)-mediated depletion of ATG7 increased MB d levels (Fig. 6b) . Induction of autophagy by rapamycin and lithilum chloride treatment 47, 48 in HeLa cells or by exogenous BECN1 expression in MCF-7 cells decreased MB d levels (Fig. 6c ). These results demonstrate the role of autophagy in regulating MB d levels in different cell types, and indicate an inverse relationship between autophagic activity and MB d accumulation. This inverse relationship was revealed in 12 cell lines by microtubule-associated protein light chain 3-II (LC3-II) (refs 44,49) or p62-based (refs 44,50,51) measurements of autophagic activity (Fig. 6d,e and Supplementary  Fig. S4b ). We conclude that MB d levels are, in part, modulated by cell type/lineage-specific autophagy (Figs 3g-i, 4a, 6d,e) .
NBR1 is an autophagic receptor for MB d -specific degradation
To test whether MB d degradation involves non-specific or receptormediated autophagy pathways 15 , we investigated the mammalian autophagic receptors p62 (refs 50-52) and NBR1 (refs 53,54) . p62 is implicated in MB d clearance 12 , whereas NBR1 is untested. NBR1 and p62 localized to mitotic midbodies and MB d s (Fig. 7a, top (Fig. 7b,c) or NBR1 recruitment to MB d s (Fig. 7a, bottom) .
So far, no MB d targets for autophagic degradation have been identified. Candidate-based screening revealed that endogenous NBR1 co-immunoprecipitated with the midbody protein CEP55 in hRPE-1 cells (Fig. 7d) . CEP55 overexpression increased MB d levels (Fig. 7e ) and the level of NBR1-negative MB d s (Fig. 7f) , presumably through NBR1 sequestration in the cytoplasm (Fig. 7g ). This indicated a role for CEP55 in NBR1-mediated MB d degradation. We propose that the CEP55-NBR1 interaction couples MB d s to the autophagic machinery to control MB d fate.
Cells enriched in MB d s exhibit increased reprogramming efficiency
We next examined the functional consequences of manipulating MB d levels. We first tested the role of MB d s during reprogramming 34, 35, 55 in cells stably expressing NBR1-specific short hairpin RNAs (shRNAs) to increase MB d levels over controls (non-targeting shRNA, shNT). following NBR1 depletion occurred without significant changes in global autophagic activity (dH1f; Fig. 8c ) or cell proliferation rate (NBR1 shRNA, 27.3 ± 2.5 h; shNT, 26.8 ± 4.5 h; n = 6), indicating that NBR1 is selective for MB d degradation.
Cancer cells enriched in MB d s exhibit increased in vitro tumorigenicity
Because MB d s selectively accumulate in stem-cell niches, hESCs and iPSCs, we reasoned that they may also accumulate in CSCs. On the basis of Hoechst 33343 extrusion, the side population of MCF-7 cells 56 was isolated. These putative CSCs showed a sevenfold increase in MB d+ cells over the non-side-population (MP; Fig. 8d ).
To directly address the role of MB d s in cancer cells, MKLP1-GFPexpressing HeLa populations with high or low percentages of MB d+ cells were isolated by FACS, and tested for anchorage-independent growth. Increased colony formation was observed in the 'MB d -high' versus the 'MB d -low' population, and colony formation increased with increasing MB d levels (up to fourfold; Fig. 8e ). An increase in colony formation was also observed in MB d -enriched HeLa cells (Fig. 8f, left) and mouse hepatocarcinoma cells (134-4; Fig. 8f, right) following NBR1 silencing. Results of all three strategies indicate that MB d s in cancer cell subpopulations may contribute to their tumorigenic potential. Our findings indicate that the MB d loss that accompanies stem-cell differentiation is mediated by autophagic degradation, resulting in selective elimination of MB d s in differentiated cells but retention in germ or stem cells. This process is intriguingly similar to clearance of P granule components in committed somatic cells of Caenorhabditis elegans, which is also mediated by autophagy 57 . Moreover, P granules contain molecules required for cell-fate specification 58 , and MB d s contain stem-cell markers 13, 14 and enhance cell-fate conversion (present study). It is thus tempting to propose that MB d s may serve as scaffolds for organizing cell-fate determinants. Equally intriguing is the observation that essentially all cancer cells examined contain MB d -accumulating subpopulations, making this a common intrinsic property of both stem cells and cancer cells. The observation that MB d -enriched cancer subpopulations exhibit enhanced in vitro tumorigenicity is consistent with the CSC model for potentiation of tumorigenicity [37] [38] [39] [40] . Our data identify two primary mechanisms for MB d accumulation. The first is asymmetric MB d inheritance by the daughter cell with the older centrosome (Fig. 8g, top) . In fly testes and mouse neocortex, the old centrosome segregates to the stem cell during asymmetric divisions and is accompanied by increased microtubule-anchoring ability [4] [5] [6] . MB d inheritance could be facilitated through increased anchoring of microtubules to the older centrosome, and increased microtubule binding to the MB d in the daughter cell with the older centrosome. This would be consistent with the observed MB d accumulation in stem cells but not in their differentiated progeny. Despite the slower division rate of stem cells in vivo 59 , MB d accumulation could still occur by this mechanism. However, our results also indicate that such asymmetry occurs in different cell types, indicating that it may only be physiologically relevant in stem cells and CSCs.
A R T I C L E S
Evasion of autophagic degradation is a second mechanism for MB d accumulation (Fig. 8g, bottom) . This is exemplified by the inverse relationship between MB d levels and autophagic activity, and by changes in MB d levels with manipulation of autophagy levels. MB d accumulation can also be mediated by uncoupling receptor-mediated entry into the autophagy pathway, because depletion of the NBR1 autophagic receptor or overexpression of the corresponding ligand, CEP55, increases MB d levels. In contrast, another known autophagic receptor, p62, does not seem to be involved in MB d clearance (Fig. 7b,c) . NBR1 and p62 can form a complex 53, 60 ; however, evidence indicates that they may act independently as autophagic receptors 53 . Thus, p62-NBR1 complex formation may not be a prerequisite for autophagic degradation. Because NBR1 silencing increases MB d s to levels seen following inhibition of autophagy in HeLa cells (Figs 6b and 7b) , NBR1-mediated autophagic degradation probably represents a major pathway for selective MB d elimination. However, it is still possible that other autophagic receptors and MB d ligands may exist and contribute to MB d degradation, even though CEP55 is the sole midbody ligand for the NBR1 receptor identified thus far (Fig. 7d) 61 . The proteasome system is another major cellular degradation pathway 63 but it does not seem to play any role in MB d degradation (Supplementary Fig. S5 ). Other non-degradative processes may also regulate MB d levels. Even though elevated proliferation rate has been proposed as a factor hindering autophagic MB d degradation and causing MB d accumulation in cancer and normal cells 12 , we did not observe such a correlation (Fig. 4a) . Further work is required to determine if MB d accumulation also requires selective sequestration of previously inherited (preexisting) MB d s, as indicated by selective accumulation of MB d s in stem cells of the testes and lateral ventricle of the brain (Fig. 3a-d) . Release of MB d s has also been observed in chicken and mouse neural progenitors 13, 14 and in human cells (ref. 8 and Fig. 1g 
